Informatics

New educational series to address how to fulfill the potential of biomedical diagnostics to improve human health

Retrieved on: 
Thursday, June 1, 2023

This educational series will tackle the important challenges surrounding when, how and why to use diagnostics to improve the current healthcare system.

Key Points: 
  • This educational series will tackle the important challenges surrounding when, how and why to use diagnostics to improve the current healthcare system.
  • "At the College of Health Solutions, we value our strong collaborations with industry partners like Thermo Fisher Scientific," Deborah Helitzer, dean of the College of Health Solutions, said.
  • Thermo Fisher Scientific is a perfect teammate for this series to elevate the field of biomedical diagnostics."
  • The first three of the ASU / Thermo Fisher Scientific series will be presented online and available to all at no cost.

Global Laboratory Information Management System Market Report 2023: Low Implementation Costs, Effective Time Management and Easier Compliance Drive Adoption

Retrieved on: 
Thursday, June 1, 2023

The Global Laboratory Information Management System Market was valued at US$ 2.4 Bn in 2022, estimated to reach US$ 4.7 Bn by 2030, with a CAGR of 8.21% from 2023-2030.

Key Points: 
  • The Global Laboratory Information Management System Market was valued at US$ 2.4 Bn in 2022, estimated to reach US$ 4.7 Bn by 2030, with a CAGR of 8.21% from 2023-2030.
  • In addition, the Laboratory Information Management System (LIMS) business is growing as a result of low implementation costs, effective time management, and compliance with GDP, GCP, and GMP.
  • The scope of the Global Laboratory Information Management System Market covers segmentation based on Type, Application, Deployment, and Region.
  • The Global Laboratory Information Management System Market is segmented into 5 main regions, namely, North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

VieCure Launches Pilot Program with Clarified Precision Medicine at ALCC to Accelerate the Adoption of Precision Oncology

Retrieved on: 
Wednesday, May 31, 2023

The VieCure-Clarified partnership offers a precision oncology expert consideration, where elite, expert precision medicine guidance can be accessed while using the VieCure clinical decision support platform.

Key Points: 
  • The VieCure-Clarified partnership offers a precision oncology expert consideration, where elite, expert precision medicine guidance can be accessed while using the VieCure clinical decision support platform.
  • VieCure will integrate the Clarified Medicine Precision testing tools within its platform and make the Clarified offering available to oncologists and clinical users later this year.
  • VieCure will launch a pilot program at Alabama Cancer Care, granting early access to the ClarifiedSelect Report embedded in the VieCure platform.
  • “VieCure and Clarified Precision Medicine, together, are further democratizing precision oncology and making it easier for community oncologists to offer the right care for the right patient every time,” said Dr. Fred Ashbury, Chief Scientific Officer at VieCure.

ALMADEN GENOMICS NAMES BOARD OF ADVISORS

Retrieved on: 
Wednesday, May 31, 2023

DALLAS, May 31, 2023 /PRNewswire/ -- Almaden Genomics has announced its Board of Advisors, a highly regarded group of healthcare leaders from both the public and private sectors with experience in cancer research, presicion medicine, biotechnology, clinical trials, bioinformatics, data visualization, computational analysis, pharmacology, and AI.

Key Points: 
  • DALLAS, May 31, 2023 /PRNewswire/ -- Almaden Genomics has announced its Board of Advisors, a highly regarded group of healthcare leaders from both the public and private sectors with experience in cancer research, presicion medicine, biotechnology, clinical trials, bioinformatics, data visualization, computational analysis, pharmacology, and AI.
  • The Board – which includes Adrian Lee, Ph.D., Samir Courdy; Rayna Herman; Graham Hughes, M.D.
  • "Our first Board of Advisors is a team of respected industry giants upon whose shoulders we can embolden our existing team of talented bioinformaticians, engineers, and industry professionals," said David Gascoigne, Chief Executive Officer of Almaden Genomics.
  • Launched in 2022, Almaden Genomics is the latest in a series of spinoffs by Catalyze Dallas to speed time-to-market for technology harvested from the Fortune 100.

University of Manchester Study Using uMotif Next-Generation eCOA/ePRO Data Capture App Reveals Significant Ethnic Disparities in Pain Recognition and Management

Retrieved on: 
Wednesday, May 31, 2023

BOSTON and LONDON, May 31, 2023 /PRNewswire-PRWeb/ -- How people identify and report pain varies based on ethnicity, according to a University of Manchester study. The study, in collaboration with uMotif, was based on the novel Manchester Digital Pain Manikin self-reporting app which was used by participants to record their pain.

Key Points: 
  • The study, in collaboration with uMotif , was based on the novel Manchester Digital Pain Manikin self-reporting app which was used by participants to record their pain.
  • Chronic pain, which affects approximately 28 million people in the UK alone, can create a personal and economic burden.
  • It is essential to accurately measure pain, know its causes, and estimate its impact on people's lives.
  • uMotif Co-founder and Chief Design Officer Ben James ( LinkedIn ) said, "It was an honor for the Digital Pain Manikin app to be used in such an important study.

PacBio Announces the Appointment of Olga Troyanskaya from Princeton University to the Scientific Advisory Board

Retrieved on: 
Tuesday, May 30, 2023

MENLO PARK, Calif., May 30, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of Olga Troyanskaya, Ph.D., Professor of Computer Science and the Lewis Sigler Institute for Integrative Genomics at Princeton University to PacBio's Scientific Advisory Board (SAB) and Jay Shendure, Ph.D. as Chair. Dr. Shendure is a Professor of Genome Sciences at the University of Washington.

Key Points: 
  • "I am so honored to have Dr. Troyanskaya join PacBio's Scientific Advisory Board," said Christian Henry, President and Chief Executive Officer of PacBio.
  • Dr. Shendure has been a member of the Scientific Advisory Board since its inception and his contributions are critical to our success."
  • "I'm looking forward to working with PacBio and the other Scientific Advisory Board members and learning from them," said Dr. Troyanskaya.
  • "I want to thank Dr. Puglisi for his dedication to the Scientific Advisory Board," said Mark Van Oene, Chief Operating Officer at PacBio.

Global NGS Data Storage Market 2023 to 2033: Data Compression Efforts by Companies Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Friday, May 26, 2023

The global NGS data storage market is projected to reach $6.96 billion by 2033 from $1.13 billion in 2022, growing at a CAGR of 18.02% during the forecast period 2023-2033.

Key Points: 
  • The global NGS data storage market is projected to reach $6.96 billion by 2033 from $1.13 billion in 2022, growing at a CAGR of 18.02% during the forecast period 2023-2033.
  • Several companies have developed NGS informatics solutions to aid healthcare institutions and academic research centers.
  • NGS data is critical to researchers that offer storage solutions that are reliable while being easy to manage.
  • These services offer pay-as-you-go models, which make it easier for researchers to manage costs based on their data storage needs.

Harvard Professor and Entrepreneur Tim Springer Donates $210 Million to the Institute for Protein Innovation

Retrieved on: 
Wednesday, May 24, 2023

The Institute for Protein Innovation (IPI) , a nonprofit research organization, announced today a $210 million gift from Tim Springer, Ph.D., veteran entrepreneur and professor at Harvard Medical School and Boston Children’s Hospital, who founded IPI in 2017 with Andrew Kruse, Ph.D.

Key Points: 
  • The Institute for Protein Innovation (IPI) , a nonprofit research organization, announced today a $210 million gift from Tim Springer, Ph.D., veteran entrepreneur and professor at Harvard Medical School and Boston Children’s Hospital, who founded IPI in 2017 with Andrew Kruse, Ph.D.
  • The philanthropic gift—made by Springer, his wife Chafen Lu, Ph.D., and their children—adds to previous gifts of $40 million to IPI from Springer himself.
  • “Thanks to Tim’s commitment, IPI will be able to take on more challenging problems in protein science that academia and industry cannot or will not.
  • Springer has previously endowed professorships and chairs at Harvard Medical School, Boston Children's Hospital and the University of California, Berkeley.

Telemetrix promotes Nancy Beale, PhD, RN-BC to President

Retrieved on: 
Tuesday, May 23, 2023

Telemetrix announced today that Nancy Beale, PhD, RN-BC has been promoted to President of the company from her prior role as Chief Nurse Executive/Chief Clinical Informatics Officer.

Key Points: 
  • Telemetrix announced today that Nancy Beale, PhD, RN-BC has been promoted to President of the company from her prior role as Chief Nurse Executive/Chief Clinical Informatics Officer.
  • With the addition of Nancy two years ago, Telemetrix has grown into a world-class operation through her leadership and operational oversight.
  • “By promoting Nancy to President, Nancy will continue overseeing the day-to-day streamlining of technical and clinical operations and expand the team to offer additional services.
  • “I am excited to take on the challenge of leading Telemetrix and affiliates in the role of President.

Global Medical Imaging Equipment and Informatics Market Outlook 2023: Marketplace Platforms in Radiology Will Be in the Spotlight, Enabling SaaS-based Solutions

Retrieved on: 
Thursday, May 25, 2023

DUBLIN, May 25, 2023 /PRNewswire/ -- The "Global Medical Imaging Equipment and Informatics Market Outlook 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, May 25, 2023 /PRNewswire/ -- The "Global Medical Imaging Equipment and Informatics Market Outlook 2023" report has been added to ResearchAndMarkets.com's offering.
  • The global medical imaging equipment and informatics market is experiencing a surge in innovative manufacturing and supply chain management techniques that enable the uninterrupted supply of imaging equipment.
  • In addition, cloud-based artificial intelligence (AI) capabilities, advanced analytics, and AI/machine learning drive the adoption of enterprise imaging IT solutions in developed and developing economies.
  • The analyst segments the market into medical imaging equipment and informatics, defining subsegments for each.